Related Experiment Video
Updated: Aug 5, 2025

03:55
Author Spotlight: Enhancing Grasping Abilities for Hemiplegic Patients with Flexible Robotic Limbs
Published on: October 27, 2023
2.2K
Botulinum Toxin and Dynamic Splint Restore Grasping Function after Stroke: A Case Report
Denis Moskiewicz1,2, Małgorzata Mraz1, Dagmara Chamela-Bilińska1
1Department of Physiotherapy, Wroclaw University of Health and Sport Sciences, 51-612 Wrocław, Poland.
Summary
This study shows that a 16-week program combining botulinum toxin injections and a dynamic splint improved upper extremity function and reduced spasticity in a stroke patient. The treatment enhanced grasping ability and quality of life.
Area of Science:
- Neurorehabilitation
- Clinical Neurology
- Physical Medicine and Rehabilitation
Background:
- Evidence regarding upper extremity rehabilitation post-stroke remains inconclusive.
- Muscle spasticity significantly impairs motor function and quality of life in stroke survivors.
- Botulinum toxin injections and dynamic splinting are potential therapeutic interventions for upper extremity spasticity.
Observation:
- A 43-year-old female with chronic spastic hemiparesis post-ischemic stroke presented with severe left upper extremity mobility impairment.
- A 16-week intensive therapeutic program involved daily sessions focusing on grasping and releasing exercises, with and without a dynamic splint (SaeboFlex®).
- Treatment was augmented with botulinum toxin injections, with evaluations conducted pre-injection and at 6, 12, and 16 weeks.
Findings:
- Significant motor function improvement observed, with a 19.7% increase on the Fugl-Meyer Upper Extremity Assessment (FMA-UE).
- Spasticity reduced by one degree on the Modified Ashworth Scale, and pain decreased by one point on the Numerical Rating Scale (NRS).
- Objective measures indicated reduced muscle oscillation frequency and stiffness; patient regained grasping function and reported a 35% improvement in health-related quality of life.
Implications:
- The combined therapy of botulinum toxin and dynamic splinting effectively reduces disability and enhances quality of life in chronic spastic hemiparesis.
- This case study suggests a promising multimodal approach for upper extremity rehabilitation post-stroke.
- Further research is warranted to validate these findings in larger cohorts and explore long-term outcomes.
More Related Videos
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
718
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
718
Skeletal Muscle Relaxants: Therapeutic Uses
535
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
535

